新生學校財團法人新生醫護管理專科學校圖書館 |

Language: English

Back

Disease-modifying therapy in vasculi...

Tervaert, Jan W. Cohen.

Disease-modifying therapy in vasculitides /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Disease-modifying therapy in vasculitides // Cees G.M. Kallenberg, Jan W. Cohen Tervaert, editors.
other author:	Tervaert, Jan W. Cohen.
Published:	Boston :Birkhauser Verlag, : Basel ;,
Description:	viii, 204 p. :ill. ; : 24 cm.;
Subject:	Vasculitis - therapy. -
ISBN:	3764361476 (alk. paper) :

Disease-modifying therapy in vasculitides /
Disease-modifying therapy in vasculitides /Cees G.M. Kallenberg, Jan W. Cohen Tervaert, editors. - Boston :Birkhauser Verlag,Basel ; - viii, 204 p. :ill. ;24 cm. - Progress in inflammation research. - PIR (Series).

Includes bibliographical references and index.

Systemic vasculitides, an introduction -- Standard therapeutic regimens for vasculitis -- Tumor nectrosis factor (TNF) inhibition in the treatment of vasculitis -- Methotrexate as an alternative to classic immunosuppressive therapies -- Intravenous immunoglobulin as immuno-modifying treatment -- T-cell directed treatment: anti-thymocyte globulin -- New immunosuppressants: mycophenolate mofetil and 15-deoxyspergualin -- Interferon- ga s for the treatment of virus-related systemic vasculitides -- Autologous stem cell therapy for systemic vasculitis -- Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody related necrotizing small-vessel vasculitis: the role for autoantibody guided and anti-bacterial treatment.

ISBN: 3764361476 (alk. paper) :NT3643

LCCN: 緅010258903Subjects--Topical Terms:

72049
Vasculitis
--therapy.

LC Class. No.: RC694.5.I53 / D55 2001

Dewey Class. No.: 616.1/3

National Library of Medicine Call No.: WG 515 D611 2001

Disease-modifying therapy in vasculitides /
LDR:01506cam0 22002411 450L 001 53207
003 OCoLC
005 2005020284557.0
008 090515s2001 sz a b 001 0 eng c
010 $a 緅010258903
020 $a 3764361476 (alk. paper) : $c NT3643
035 $a 1044612
040 $a DNLM/DLC $c DLC $d SQU $d TJM $d OCLCQ
042 $a pcc
050 1 0 $a RC694.5.I53 $b D55 2001
060 $a WG 515 D611 2001
082 0 0 $a 616.1/3 $2 21
090 $a WG515/D611/////B002600
245 0 0 $a Disease-modifying therapy in vasculitides / $c Cees G.M. Kallenberg, Jan W. Cohen Tervaert, editors.
260 $c Basel ; $a Boston : $c 2001 $b Birkhauser Verlag,
300 $a viii, 204 p. : $b ill. ; $c 24 cm.
490 1 $a Progress in inflammation research
504 $a Includes bibliographical references and index.
505 0 $a Systemic vasculitides, an introduction -- Standard therapeutic regimens for vasculitis -- Tumor nectrosis factor (TNF) inhibition in the treatment of vasculitis -- Methotrexate as an alternative to classic immunosuppressive therapies -- Intravenous immunoglobulin as immuno-modifying treatment -- T-cell directed treatment: anti-thymocyte globulin -- New immunosuppressants: mycophenolate mofetil and 15-deoxyspergualin -- Interferon- ga s for the treatment of virus-related systemic vasculitides -- Autologous stem cell therapy for systemic vasculitis -- Prevention of relapsing disease in anti-neutrophil cytoplasmic antibody related necrotizing small-vessel vasculitis: the role for autoantibody guided and anti-bacterial treatment.
650 $a Vasculitis $x therapy. $3 72049
650 $a Vasculitis. $3 72048
700 $a Tervaert, Jan W. Cohen. $3 72047
700 $a Kallenberg, Cornelis Gijsbertus Maria. $3 72046
830 $a PIR (Series) $3 72050